IP 3 receptor antagonist, 2-APB, attenuates cisplatin induced Ca 2+-influx in HeLa-S3 cells and prevents activation of calpain and induction of apoptosis

F. Splettstoesser, A. M. Florea, Dietrich Busselberg

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Background and purpose: Cisplatin drives specific types of tumour cells to apoptosis. In this study we investigate the involvement of intracellular calcium ([Ca 2+] i) in triggering apoptosis in two different cell lines. As cisplatin is used for the treatment of several forms of cancer we choose HeLa-S3 and U2-OS as two examples of tumour cell lines. Experimental approach: Cisplatin (1nM-10μM) was applied to HeLa-S3 and U2-OS cells and [Ca 2+] i measured with fluo-4, using laser scanning microscopy. Inositol-1,4,5-trisphosphate (IP 3) receptors were visualized with immunostaining. Membrane conductances were measured with patch-clamp techniques. Levels of calpain and caspases were assessed by western blots and apoptotic cells were stained with Hoechst 33342 and counted. Key results: Cisplatin increases [Ca 2+] i concentration- dependently in HeLa-S3 but not in U2-OS cells. This elevation of [Ca 2+] i depended on extracellular Ca 2+ but was reduced by the IP 3 receptor blocker, 2-APB. This effect was not due to a Ca 2+ release triggered by Ca 2+ entry. Immunostaining showed IP 3-receptors (type1-3) at the cellular membrane of HeLa-S3 cells, but not in U2-OS cells. Electrophysiological experiments showed an increased membrane conductance with cisplatin only when Ca 2+ was present extracellularly. Increase of [Ca 2+] i was related to the activation of calpain but not caspase-8 and triggered apoptosis in HeLa-S3 but not in U2-OS cells. Conclusions and implications: Our observations on the activation of IP 3-receptors, calcium entry and apoptotic rate by cisplatin in specific carcinogenic cells might open new possibilities in the treatment of some forms of cancer.

Original languageEnglish
Pages (from-to)1176-1186
Number of pages11
JournalBritish Journal of Pharmacology
Volume151
Issue number8
DOIs
Publication statusPublished - Aug 2007
Externally publishedYes

Fingerprint

Calpain
HeLa Cells
Cisplatin
Apoptosis
Membranes
Calcium-Sensing Receptors
Neoplasms
Inositol 1,4,5-Trisphosphate
Caspase 8
Patch-Clamp Techniques
Caspases
Tumor Cell Line
Confocal Microscopy
Western Blotting
Calcium
Cell Line

Keywords

  • [Ca ]
  • Anticancer drugs
  • Apoptosis
  • Calcium signalling
  • Calcium stores
  • Calpain
  • Carboplatin
  • Cisplatin
  • HeLa-S3
  • IP -receptor
  • U2-OS

ASJC Scopus subject areas

  • Pharmacology

Cite this

@article{8df708bfa0e04199b30834751ad83ed5,
title = "IP 3 receptor antagonist, 2-APB, attenuates cisplatin induced Ca 2+-influx in HeLa-S3 cells and prevents activation of calpain and induction of apoptosis",
abstract = "Background and purpose: Cisplatin drives specific types of tumour cells to apoptosis. In this study we investigate the involvement of intracellular calcium ([Ca 2+] i) in triggering apoptosis in two different cell lines. As cisplatin is used for the treatment of several forms of cancer we choose HeLa-S3 and U2-OS as two examples of tumour cell lines. Experimental approach: Cisplatin (1nM-10μM) was applied to HeLa-S3 and U2-OS cells and [Ca 2+] i measured with fluo-4, using laser scanning microscopy. Inositol-1,4,5-trisphosphate (IP 3) receptors were visualized with immunostaining. Membrane conductances were measured with patch-clamp techniques. Levels of calpain and caspases were assessed by western blots and apoptotic cells were stained with Hoechst 33342 and counted. Key results: Cisplatin increases [Ca 2+] i concentration- dependently in HeLa-S3 but not in U2-OS cells. This elevation of [Ca 2+] i depended on extracellular Ca 2+ but was reduced by the IP 3 receptor blocker, 2-APB. This effect was not due to a Ca 2+ release triggered by Ca 2+ entry. Immunostaining showed IP 3-receptors (type1-3) at the cellular membrane of HeLa-S3 cells, but not in U2-OS cells. Electrophysiological experiments showed an increased membrane conductance with cisplatin only when Ca 2+ was present extracellularly. Increase of [Ca 2+] i was related to the activation of calpain but not caspase-8 and triggered apoptosis in HeLa-S3 but not in U2-OS cells. Conclusions and implications: Our observations on the activation of IP 3-receptors, calcium entry and apoptotic rate by cisplatin in specific carcinogenic cells might open new possibilities in the treatment of some forms of cancer.",
keywords = "[Ca ], Anticancer drugs, Apoptosis, Calcium signalling, Calcium stores, Calpain, Carboplatin, Cisplatin, HeLa-S3, IP -receptor, U2-OS",
author = "F. Splettstoesser and Florea, {A. M.} and Dietrich Busselberg",
year = "2007",
month = "8",
doi = "10.1038/sj.bjp.0707335",
language = "English",
volume = "151",
pages = "1176--1186",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - IP 3 receptor antagonist, 2-APB, attenuates cisplatin induced Ca 2+-influx in HeLa-S3 cells and prevents activation of calpain and induction of apoptosis

AU - Splettstoesser, F.

AU - Florea, A. M.

AU - Busselberg, Dietrich

PY - 2007/8

Y1 - 2007/8

N2 - Background and purpose: Cisplatin drives specific types of tumour cells to apoptosis. In this study we investigate the involvement of intracellular calcium ([Ca 2+] i) in triggering apoptosis in two different cell lines. As cisplatin is used for the treatment of several forms of cancer we choose HeLa-S3 and U2-OS as two examples of tumour cell lines. Experimental approach: Cisplatin (1nM-10μM) was applied to HeLa-S3 and U2-OS cells and [Ca 2+] i measured with fluo-4, using laser scanning microscopy. Inositol-1,4,5-trisphosphate (IP 3) receptors were visualized with immunostaining. Membrane conductances were measured with patch-clamp techniques. Levels of calpain and caspases were assessed by western blots and apoptotic cells were stained with Hoechst 33342 and counted. Key results: Cisplatin increases [Ca 2+] i concentration- dependently in HeLa-S3 but not in U2-OS cells. This elevation of [Ca 2+] i depended on extracellular Ca 2+ but was reduced by the IP 3 receptor blocker, 2-APB. This effect was not due to a Ca 2+ release triggered by Ca 2+ entry. Immunostaining showed IP 3-receptors (type1-3) at the cellular membrane of HeLa-S3 cells, but not in U2-OS cells. Electrophysiological experiments showed an increased membrane conductance with cisplatin only when Ca 2+ was present extracellularly. Increase of [Ca 2+] i was related to the activation of calpain but not caspase-8 and triggered apoptosis in HeLa-S3 but not in U2-OS cells. Conclusions and implications: Our observations on the activation of IP 3-receptors, calcium entry and apoptotic rate by cisplatin in specific carcinogenic cells might open new possibilities in the treatment of some forms of cancer.

AB - Background and purpose: Cisplatin drives specific types of tumour cells to apoptosis. In this study we investigate the involvement of intracellular calcium ([Ca 2+] i) in triggering apoptosis in two different cell lines. As cisplatin is used for the treatment of several forms of cancer we choose HeLa-S3 and U2-OS as two examples of tumour cell lines. Experimental approach: Cisplatin (1nM-10μM) was applied to HeLa-S3 and U2-OS cells and [Ca 2+] i measured with fluo-4, using laser scanning microscopy. Inositol-1,4,5-trisphosphate (IP 3) receptors were visualized with immunostaining. Membrane conductances were measured with patch-clamp techniques. Levels of calpain and caspases were assessed by western blots and apoptotic cells were stained with Hoechst 33342 and counted. Key results: Cisplatin increases [Ca 2+] i concentration- dependently in HeLa-S3 but not in U2-OS cells. This elevation of [Ca 2+] i depended on extracellular Ca 2+ but was reduced by the IP 3 receptor blocker, 2-APB. This effect was not due to a Ca 2+ release triggered by Ca 2+ entry. Immunostaining showed IP 3-receptors (type1-3) at the cellular membrane of HeLa-S3 cells, but not in U2-OS cells. Electrophysiological experiments showed an increased membrane conductance with cisplatin only when Ca 2+ was present extracellularly. Increase of [Ca 2+] i was related to the activation of calpain but not caspase-8 and triggered apoptosis in HeLa-S3 but not in U2-OS cells. Conclusions and implications: Our observations on the activation of IP 3-receptors, calcium entry and apoptotic rate by cisplatin in specific carcinogenic cells might open new possibilities in the treatment of some forms of cancer.

KW - [Ca ]

KW - Anticancer drugs

KW - Apoptosis

KW - Calcium signalling

KW - Calcium stores

KW - Calpain

KW - Carboplatin

KW - Cisplatin

KW - HeLa-S3

KW - IP -receptor

KW - U2-OS

UR - http://www.scopus.com/inward/record.url?scp=34547870107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547870107&partnerID=8YFLogxK

U2 - 10.1038/sj.bjp.0707335

DO - 10.1038/sj.bjp.0707335

M3 - Article

VL - 151

SP - 1176

EP - 1186

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 8

ER -